<DOC>
	<DOCNO>NCT00653445</DOCNO>
	<brief_summary>The purpose study compare 6 week treatment rosuvastatin alone compare 6 week treatment rosuvastatin combine ezetimibe achieve low density lipoprotein level goal .</brief_summary>
	<brief_title>Compare Safety &amp; Efficacy Rosuvastatin 40mg Combination With Ezetimibe 10mg</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>A history CHD clinical evidence atherosclerosis multiple risk factor confer high risk define protocol . Fasting LDLC concentration Visit 1 define protocol . Discontinuation lipid lower therapy Visit 1 . History statin induce serious side effect , serious hypersensitivity reaction statin . Subjects consider unstable investigator follow event : myocardial infarction ( heart attack ) , unstable angina , myocardial revascularisation another revascularisation procedure transient ischaemic attack ( TIA ) stroke . Severe congestive cardiac failure ( define protocol Appendix I ) . Subjects await plan myocardial revascularisation prior start study ( i.e . plan prior visit 1 ) ..</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Low density lipoprotein</keyword>
	<keyword>Hypercholesterolemia</keyword>
	<keyword>Coronary Heart Disease</keyword>
	<keyword>Rosuvastatin</keyword>
	<keyword>Crestor</keyword>
	<keyword>Ezetimibe</keyword>
</DOC>